|
|
|
LifeScienceHistory.com - Check us out on Instagram
New York Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing New YorkLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Fortress Biotech, Inc.
| | | Phone: | (781) 652-4500 | Year Established: | 2007 | Employees: | 4 | Ticker: | FBIO | Exchange: | NASDAQ | Main Contact: | Elisabeth Leiderman, MD, VP, Corporate Development | | Other Contacts: | Robyn Hunter, CFO Lindsay A. Rosenwald, M.D., Chairman, President & CEO Michael S. Weiss, Executive Vice Chairman, Strategic Development George Avgerinos, Ph.D., Senior VP, Biologics Operations
| | Company Description | Fortress Biotech, formerly Coronado Biosciences, is engaged in the development of novel immunotherapy biologic agents. The company's two prin,cipal pharmaceutical product candidates in clinical development are: TSO (Trichuris suis ova or CNDO-201), a biologic for the treatment of autoimmune diseases, such as Crohn's disease, ulcerative colitis and multiple sclerosis; and CNDO-109, a biologic that activates natural killer (NK) cells, for the treatment of acute myeloid leukemia (AML), multiple myeloma and solid tumors. | |
|
|
|
|
|